Product Description
Elcatonin supplier Pharmaceutical API Polypeptide Electrolyte supplement made in china 60731-46-6
AI Product Description
*The following content is generated by AI and is for reference only.
Elcatonin, a synthetic polypeptide analog of the natural hormone calcitonin, is primarily manufactured in China by leading pharmaceutical API suppliers to serve global markets. Its molecular formula is C149H236N40O48S2, with a molecular weight of approximately 3,457 g/mol. The product is identified by CAS number 11031-91-5 and belongs to the class of peptide-based therapeutics. Elcatonin is structurally derived from salmon calcitonin but modified to enhance stability and biological activity, making it particularly effective in clinical settings for bone-related disorders.
The primary therapeutic application of Elcatonin involves the management of osteoporosis, especially postmenopausal osteoporosis, where it helps inhibit osteoclast activity and reduce bone resorption. It also plays a crucial role in treating hypercalcemia associated with malignancies or immobilization. Additionally, Elcatonin is utilized as an electrolyte supplement in specific formulations to maintain calcium homeostasis and support skeletal health. Unlike some native hormones, its synthetic nature ensures consistent potency and reduced immunogenicity, which is vital for long-term therapy.
Manufactured under strict Good Manufacturing Practice (GMP) standards in China, Elcatonin APIs are exported worldwide for formulation into injectable solutions, nasal sprays, and oral preparations. The production process involves solid-phase peptide synthesis followed by rigorous purification steps such as HPLC and lyophilization to ensure high purity levels exceeding 98%. As a polypeptide drug, it requires careful storage conditions, typically at 2–8°C, to preserve structural integrity. While not classified as a traditional electrolyte supplement like sodium or potassium salts, its regulatory classification often includes supportive roles in mineral balance therapies. Global pharmaceutical companies rely on Chinese suppliers for cost-effective, high-quality Elcatonin due to advanced biotechnology infrastructure and scalable production capabilities. This molecule remains a cornerstone in endocrine and orthopedic pharmacotherapy, offering significant benefits in pain relief and fracture risk reduction for vulnerable populations.